Our mission is to push the boundaries of what is possible with MRI technology by transforming advanced research techniques into practical clinical application. We are more than a software company. We are your partner in accessing cutting edge MRI capabilities to transform clinical practice.
Patents (+2 Pending)
Years of MRI Innovation Experience
Gold Medal Award
International Society of Magnetic Resonance in Medicine
Silver Medal Award
Society of Magnetic Resonance
International Society of Neurovascular Disease
“40 under 40” Recipient
Crain’s Detroit Business, 2019
“30 in their 30s” Recipient
Innovation Award Winner
Michigan SmartZone, 2019
In 2017, a group of internationally-recognized MRI industry professionals and entrepreneurs founded SpinTech, Inc. with the goal of transforming advanced MRI techniques, previously reserved only for the research realm, into practical applications to serve clinicians, pharmaceutical companies, and researchers alike. Our core technologies leverage three decades of leadership in the field of MRI and over $10M of R&D grants and investment.
Since our founding, our team has been instrumental in scientifically and clinically proving the importance of numerous imaging biomarkers for advancing the diagnosis and treatment of a wide range of neurological conditions. Collectively, our world-class team has published over 300 papers and received over 25,000 citations, supporting and validating our technology suite. As a company, we’ve grown rapidly with strategic partners and research hospitals from around the world.
In 2021, SpinTech acquired Magnetic Resonance Innovations, Inc. which began as a research and development and technology incubation company in 1994. Now as a combined entity, the company holds a robust patent portfolio with a continuous, rapid pace of innovation and development.
SpinTech continues to extend the boundaries of MRI and recently earned FDA clearance for STAGE, a rapid, quantitative multi-contrast imaging software that integrates seamlessly into existing clinical workflows. STAGE includes the world’s first FDA cleared QSM output and can be used across a wide range of neurodegenerative disorders such as stroke, Multiple Sclerosis, Parkinson’s, traumatic brain injury, dementia, and tumor imaging. In addition, SpinTech offers automated CMB and Parkinson’s Reports that run on top of STAGE data to aid clinicians in detecting microbleeds and quantifying neuromelanin content, respectively.
Meet Our Team
From fully-integrated research and development to innovative protocol and image processing software, SpinTech’s team leverages 20+ years of MRI expertise to offer end-to-end MRI technology development.